(Q37024885)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18060548%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

review article

1 reference

title

Urinary markers in screening patients with hematuria (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18060548%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18060548%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Kris E Gaston

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18060548%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

H Barton Grossman

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18060548%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

4 December 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18060548%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

published in

World Journal of Urology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18060548%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18060548%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18060548%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

25-30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18060548%20AND%20SRC:MED&resulttype=core&format=json

Urinary dosage of nuclear matrix protein 22 (NMP22) like biologic marker of transitional cell carcinoma (TCC): a study on patients with hematuria

29 December 2019

cites work

1 reference

12 December 2020

Diagnostic delay and prognosis in invasive bladder cancer

1 reference

12 December 2020

Evaluation of nuclear matrix protein 22 (NMP22) as a tumor marker in the detection of bladder cancer

1 reference

12 December 2020

Detection of bladder cancer using a point-of-care proteomic assay

1 reference

12 December 2020

Delay and survival in bladder cancer

1 reference

12 December 2020

Long-term outcome of hematuria home screening for bladder cancer in men

1 reference

12 December 2020

Identification of a nuclear protein matrix.

1 reference

12 December 2020

Should we screen for bladder cancer in a high-risk population?: A cost per life-year saved analysis

1 reference

12 December 2020

Urinary level of nuclear matrix protein 22 in the diagnosis of bladder cancer: experience with 130 patients with biopsy confirmed tumor

1 reference

12 December 2020

Delaying Radical Cystectomy for Muscle Invasive Bladder Cancer Results in Worse Pathological Stage

1 reference

12 December 2020

Evaluation of NMP22 in the detection of transitional cell carcinoma of the bladder

1 reference

12 December 2020

Variability in the performance of nuclear matrix protein 22 for the detection of bladder cancer.

1 reference

12 December 2020

Nuclear matrix proteins in human colon cancer

1 reference

12 December 2020

Comparative predictive values of urinary cytology, urinary bladder cancer antigen, CYFRA 21-1 and NMP22 for evaluating symptomatic patients at risk for bladder cancer

1 reference

12 December 2020

Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer

1 reference

12 December 2020

The nuclear matrix: defining structural and functional roles

1 reference

12 December 2020

Diagnostic Utility of the ImmunoCyt/uCyt+ Test in Bladder Cancer

1 reference

12 December 2020

Urine detection of survivin is a sensitive marker for the noninvasive diagnosis of bladder cancer

1 reference

12 December 2020

Exclusion criteria enhance the specificity and positive predictive value of NMP22 and BTA stat

1 reference

12 December 2020

[Evaluation of usefulness of urinary nuclear matrix protein 22 (NMP22) in the detection of urothelial transitional cell carcinoma]

1 reference

12 December 2020

[Evaluation of urinary NMP22 (nuclear matrix protein 22) as a diagnostic marker for urothelial cancer--screening for urothelial cancer in patients with microscopic hematuria. NMP Study Group]

1 reference

12 December 2020

Urinary NMP22 for the detection of recurrence after transurethral resection of transitional cell carcinoma of the bladder: experience on 137 patients

1 reference

12 December 2020

Clinical utility of a multiprobe FISH assay in voided urine specimens for the detection of bladder cancer and its recurrences, compared with urinary cytology

1 reference

12 December 2020

Nuclear matrix proteins in normal and breast cancer cells

1 reference

12 December 2020

Screening and monitoring for bladder cancer: refining the use of NMP22

1 reference

12 December 2020

Evaluation of nuclear matrix protein 22 as a tumour marker in the detection of transitional cell carcinoma of the bladder

1 reference

12 December 2020

Urinary nuclear matrix protein as a marker for transitional cell carcinoma of the urinary tract

1 reference

12 December 2020

Urinary nuclear matrix protein 22 as a new marker for the screening of urothelial cancer in patients with microscopic hematuria

1 reference

12 December 2020

Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment

1 reference

12 December 2020

The addition of urinary urokinase-type plasminogen activator to urinary nuclear matrix protein 22 and cytology improves the detection of bladder cancer

1 reference

12 December 2020

A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma

1 reference

12 December 2020

Risk stratification for bladder tumor recurrence, stage and grade by urinary nuclear matrix protein 22 and cytology

1 reference

12 December 2020

Clinical application of NMP22 and urinary cytology in patients with hematuria or a history of urothelial carcinoma

1 reference

12 December 2020

Nuclear matrix and the regulation of gene expression: tissue specificity

1 reference

12 December 2020

An international telecytologic quiz on urinary cytology reveals educational deficits and absence of a commonly used classification system.

1 reference

12 December 2020

The health economics of bladder cancer: a comprehensive review of the published literature.

1 reference

12 December 2020

An interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma

1 reference

12 December 2020

Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria

1 reference

12 December 2020

Detection of nuclear matrix proteins in serum from cancer patients

1 reference

12 December 2020

Nuclear matrix protein patterns in human benign prostatic hyperplasia and prostate cancer

1 reference

12 December 2020

Nuclear matrix proteins distinguish normal diploid osteoblasts from osteosarcoma cells.

1 reference

12 December 2020

Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy--part II: patient evaluation, cytology, voided markers, imaging, cystoscopy, nephrology evaluation, and follow-up

1 reference

12 December 2020

Cancer statistics, 2007

1 reference

12 December 2020

10.1007/S00345-007-0229-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18060548%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference